MINI FUTURE BULL - IPSEN | Market Closed - Euronext Paris 17:30:01 24/05/2024 BST | ||
| 1.38 EUR | -2.13% |
|
| Current month | +38.00% | ||
| 1 month | +50.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change |
|---|---|---|
| 24/05/24 | 1.38 | -2.13% |
| 23/05/24 | 1.41 | +5.22% |
| 22/05/24 | 1.34 | +3.08% |
| 21/05/24 | 1.3 | 0.00% |
| 20/05/24 | 1.3 | +2.36% |
Real-time Euronext Paris
Last update May 24, 2024 at 05:30 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
UniCredit
|
| C248T | |
| ISIN | DE000HD4ED76 |
| Date issued | 05/04/2024 |
| Strike | 96.01 € |
| Maturity | Unlimited |
| Parity | 20 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.45 € |
|---|---|
| Lowest since issue | 0.59 € |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
123.4
EUR
Average target price
126.4
EUR
Spread / Average Target
+2.43%
- Stock Market
- Certificates
- C248T Certificat
